Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 2, 2009, Pages 579-587

  Bogulavsky, Johanna J ^a   Gregus, Ann M ^a   Kim, Paul T H ^a   Costa, Alberto C S ^b   Rajadhyaksha, Anjali M ^a   Inturrisi, Charles E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMATE RECEPTOR 5; KAINIC ACID RECEPTOR; MORPHINE; MORPHINE 3 GLUCURONIDE; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DISPOSITION; DRUG MECHANISM; LOCOMOTION; MALE; MECHANICAL STIMULATION; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PAIN THRESHOLD; PLACE PREFERENCE; PRIORITY JOURNAL; THERMAL STIMULATION; WITHDRAWAL SYNDROME;

ANIMALS; DRUG TOLERANCE; FEMALE; GENE DELETION; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DERIVATIVES; PHYSIOLOGICAL PROCESSES; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID;

EID: 59649093195     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.144121     Document Type: Article

References (38)

1. Bettler B, Boulter J, Hermans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, and Heinemann S (1990) Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron 5:583-595.
2. Bischoff S, Barhanin J, Bettler B, Mulle C, and Heinemann S (1997) Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J Comp Neurol 379:541-562.
3. Bleakman R, Schoepp DD, Ballyk B, Bufton H, Sharpe EF, Thomas K, Ornstein PL, and Kamboj RK (1996) Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2- (1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid. Mol Pharmacol 49:581-585.
4. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723.
5. Carlezon WA Jr, Rasmussen K, and Nestler EJ (1999) AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse 31:256-262.
6. Casassus G and Mulle C (2002) Functional characterization of kainate receptors in the mouse nucleus accumbens. Neuropharmacology 42:603-611.
7. Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
8. Contractor A, Swanson GT, Sailer A, O'Gorman S, and Heinemann SF (2000) Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J Neurosci 20:8269-8278.
9. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, et al. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132:107-124.
10. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
11. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
12. Harris GC, Wimmer M, Byrne R, and Aston-Jones G (2004) Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine. Neuroscience 129:841-847.
13. Inturrisi C (1997) Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Semin Neurosci 9:110-119.
14. Ji RR, Kohno T, Moore KA, and Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696-705.
15. Kauer JA and Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858.
16. Kest B, McLemore G, Kao B, and Inturrisi CE (1997) The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. J Pharmacol Exp Ther 283:1249-1255.
17. King T, Ossipov MH, Vanderah TW, Porreca F, and Lai J (2005) Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14:194-205.
18. Ko S, Zhao MG, Toyoda H, Qiu CS, and Zhuo M (2005) Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice. J Neurosci 25:977-984.
19. Kolesnikov Y, Jain S, Wilson R, and Pasternak GW (1998) Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect. J Pharmacol Exp Ther 284:455-459.
20. Layer RT, Uretsky NJ, and Wallace LJ (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res 617:267-273.
21. Li X, Angst MS, and Clark JD (2001) A murine model of opioid-induced hyperalgesia. Molecular Brain Research 86:56-62.
22. Liu JG and Anand KJ (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1-19.
23. McLemore GL, Kest B, and Inturrisi CE (1997) The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res 778:120-126.
24. Mulle C, Sailer A, Swanson GT, Brana C, O'Gorman S, Bettler B, and Heinemann SF (2000) Subunit composition of kainate receptors in hippocampal interneurons. Neuron 28:475-484.
25. Ornstein PL, Arnold MB, Augenstein NK, Lodge D, Leander JD, and Schoepp DD (1993) (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3- carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. J Med Chem 36:2046-2048.
26. Pasternak GW, Kolesnikov YA, and Babey AM (1995) Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13:309-313.
27. Pinheiro P and Mulle C (2006) Kainate receptors. Cell Tissue Res 326:457-482.
28. Rasmussen K and Vandergriff J (2003) The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal. Neuropharmacology 44:88-92.
29. Sailer A, Swanson GT, Pérez-Otaño I, O'Leary L, Malkmus SA, Dyck RH, Dickinson-Anson H, Schiffer HH, Maron C, Yaksh TL, Gage FH, O'Gorman S, and Heinemann SF (1999) Generation and analysis of GluR5(Q636R) kainate receptor mutant mice. J Neurosci 19:8757-8764.
30. Sang CN, Hostetter MP, Gracely RH, Chappell AS, Schoepp DD, Lee G, Whitcup S, Caruso R, and Max MB (1998) AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 89:1060-1067.
31. Shabat-Simon M, Levy D, Amir A, Rehavi M, and Zangen A (2008) Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area. J Neurosci 28:8406-8416.
32. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, and Iyengar S (1998) Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37:25-36.
33. Smith FL, Gabra BH, Smith PA, Redwood MC, and Dewey WL (2007) Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain 127:129-139.
34. Vanderschuren LJ and Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120.
35. Walters CL, Godfrey M, Li X, and Blendy JA (2005) Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice. Brain Res 1032:193-199.
36. Xu H, Wu LJ, Zhao MG, Toyoda H, Vadakkan KI, Jia Y, Pinaud R, and Zhuo M (2006) Presynaptic regulation of the inhibitory transmission by GluR5-containing kainate receptors in spinal substantia gelatinosa. Mol Pain 2:29.
37. Zeitz KP, Malmberg AB, Gilbert H, and Basbaum AI (2001) Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice. Pain 94:245-253.
38. Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly T, Dahan A, Beijnen JH, and Borst P (2005) Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A 102:7274-7279.